BROOKS logo

Brooks LAB Limited

BROOKS·NSE·
66.00 -0.47 (-0.71%)
Market Cap191.91 Cr
PE Ratio7.91
Volume21,964
Day High - Low66.10 - 64.00
52W High-Low163.90 - 36.30
DocStoX Score
5.0/10
Weak
Fair Value
Sign in to see
ROE
22.30%
Strong
P/E
7.91x
Cheap
Debt / Equity
0.07
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day64.00
66.10
52W36.30
163.90
DocStoX take

Supported by valuation (9.0), but held back by momentum (1.2). Valuation looks strong at 9.0, but that is offset by momentum at 1.2. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.0
/10
Weak
Quality
Modest
ROE 22.3%
Valuation
Cheap
P/E 7.9×
Growth
Slow
Revenue +2.2% 5Y CAGR
Risk
Moderate
D/E 0.07
Momentum
Weak
23% of 52-week range

At a glance

Market Cap
₹192 Cr
52W High / Low
₹164 / ₹36
Dividend Yield
0.00%
Promoter Holding
52.62%
EPS (TTM)
₹8.34
Book Value
₹41.60

Key highlights

  • Low leverage — D/E 0.07
  • Healthy net margin (29%)
  • Undemanding at 8× earnings
  • Loss-making in some of the last 5 years
  • Momentum is weak (1.2/10)
4 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

BROOKS LAB LIMITED peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

BROOKS LAB LIMITED (BROOKS) Share Price at ₹66 (-0.71%) | DocStoX